Concord Biotech Board to Mull Bonus Issue on Sept 21
Concord Biotech's board to discuss bonus issue on Sept 21. NDTV Profit highlights Concord Biotech as a stock to watch. Source: NDTV Profit
Stock news timeline · CONCORDBIO
Concord Biotech
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
- Timeline updates
- 6
- Bullish
- 1
- Neutral
- 5
- Bearish
- 0
- Active days
- 5
News timeline
Showing 6 of 6 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Monday, 21 Sep 20261 update
Friday, 18 Sep 20262 updates
Concord Biotech Q1 Profit Jumps 33%; US FDA Clears Valthera Unit
Concord Biotech's Valthera unit cleared US FDA audit with one minor procedural observation. Company reported 32.8% rise in Q1 FY27 profit to Rs 58.53 crore; shares at Rs 1481.95, up 1.36%. Source: Business Standard
USFDA Flags Minor Issue at Concord Biotech; No Impact on Operations
USFDA inspected Concord Biotech's Ahmedabad unit; one minor observation noted. Observation unrelated to GMP, no material impact on operations expected. Source: ScoutQuest
Thursday, 17 Sep 20261 update
Concord Biotech Investor Meet on Sep 23 in Ahmedabad
Concord Biotech Ltd to hold an investor/analyst meet on Sept 23, 2026, organized by JP Morgan in Ahmedabad. Discussions will focus on publicly available info; no unpublished price-sensitive details to be shared. Source: BSE
Friday, 11 Sep 20261 update
Concord Biotech Q4 Profit ₹98.99 Cr, Stock Trades Near ₹1,473
Concord Biotech Q4 FY26 results: Operating profit ₹98.99 Cr, Total Income ₹326.08 Cr. Stock traded today at ₹1,431.70 - ₹1,473.70; sector: Biotechnology & Drugs. Source: livemint.com
Monday, 31 Aug 20261 update
DSP MF Buys 12.88 Lakh Concord Biotech Shares for ₹180.9 Cr
DSP Mutual Fund acquired 1,288,114 shares of Concord Biotech at ₹1404.1/share. The total transaction value was ₹180.9 crore on 2026-08-31. Source: ScoutQuest